Stevens-Johnson Syndrome Caused by Enzalutamide: A Case Report and Literature Review

OBJECTIVE: Enzalutamide is the most frequently prescribed compound for treating metastatic castration-resistant prostate cancer (mCRPC). Common adverse drug events of enzalutamide are febrile neutropenia, hot flashes, hypertension, and fatigue. METHODS: We present a case of a patient with mCRPC who...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Min, Chai, Huirong, Yang, Meng, Wei, Xueman, Zhang, Wenjun, Wang, Xuebin, Li, Juanjuan, Wang, Zhuo, Chen, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635634/
https://www.ncbi.nlm.nih.gov/pubmed/34868926
http://dx.doi.org/10.3389/fonc.2021.736975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635634/
https://www.ncbi.nlm.nih.gov/pubmed/34868926
http://dx.doi.org/10.3389/fonc.2021.736975

Ejemplares similares